Diarmuid joined the ATXA board as Chairperson in February 2020. Diarmuid has over 26 years of experience in the pharma industry, leading and growing an international pharmaceutical organization. His experience includes the roles of VP; MD; CFO and GM in a multi-billion-euro organization where he has broad ranging experience from establishing and building to divesting businesses. Diarmuid brings strong corporate governance along with expertise in capital expenditure; taxation; regulatory; treasury and risk management across multiple markets and cultures. He held various senior executive management roles at Forest Laboratories in Ireland, UK, Europe, most recently as VP (Europe), Forest Global Healthcare (2010-2015). He is an experienced Pharma/Biotech business strategist and board director, holding a diploma from the Institute of Directors (2011). As an experienced Non-Executive Director, Diarmuid has also contributed widely within the voluntary sector holding board positions in educational, charitable, and sporting organizations.
Current role